Cord blood stem cell therapy - Gamida Cell

Drug Profile

Cord blood stem cell therapy - Gamida Cell

Alternative Names: CordIn; NiCord; UC MSC; Umbilical cord blood stem cell therapy - Gamida Cell; Umbilical cord mesenchymal stem cells

Latest Information Update: 22 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Gamida-Cell
  • Developer Gamida-Cell; National Heart, Lung and Blood Institute
  • Class Antirheumatics; Stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hodgkin's disease; Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma; Myelodysplastic syndromes; Haematological malignancies
  • New Molecular Entity No

Highest Development Phases

  • Phase III Haematological malignancies
  • Phase I/II Aplastic anaemia; Haemoglobinopathies; Myelodysplastic syndromes; Sickle cell anaemia; Thalassaemia
  • No development reported Autoimmune disorders; Metabolic disorders

Most Recent Events

  • 19 Mar 2018 Updated efficacy data from a phase II trial in Haematologic malignancies released by Gamida Cell
  • 21 Feb 2018 Efficacy and adverse events data from a phase I/II trial in Sickle cell disease released by Gamida Cell
  • 11 Dec 2017 Final efficacy and adverse events data from a phase I/II trial in Haematological malignancies presented at the Annual meeting of the American Society of Haematology (ASH-2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top